About: covid:f8183747af9357b5842723b8419cd58347362e0b

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:f8183747af9357b5842723b8419cd58347362e0b Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Matthews, David De Silva, Nipun Dissanayake, Harsha Gamage, Kavinga Katulanda, Prasad Piyumi, & Ranathunga, Ishara Ratnasamy, Vithiya Somasundaram, Noel Sumanatilleke, Manilka Wijewickrama, S Yogendranathan, Nilukshana
is schema:about of	named entity 'group' named entity 'This' named entity 'Since' named entity 'risk' named entity 'immunomodulatory' named entity 'rapidly' named entity 'chemoprophylaxis' named entity 'COVID-19' named entity 'injury' named entity 'diabetes' named entity 'pandemic' named entity 'insulin' named entity 'direct' named entity 'disease' named entity 'access' named entity 'patients' named entity 'medications' named entity 'COVID-19' named entity 'Measures' named entity 'coronavirus disease 2019' named entity 'COVID-19' named entity 'inflammatory response' named entity 'glycaemic control' named entity 'healthcare' named entity 'recognised' named entity 'vulnerable' named entity 'severe' named entity 'COVID-19' named entity 'people with diabetes' named entity 'diabetes' named entity 'prevent disease' named entity 'inflammatory response' named entity 'people with diabetes' named entity 'People with diabetes' named entity 'people with diabetes' named entity 'chemoprophylaxis' named entity 'Older' named entity 'diabetes' named entity 'diabetes' named entity 'ARDS' named entity 'China' named entity 'acute illness' named entity 'angiotensin' named entity 'pneumonic' named entity 'Text box' named entity 'ACE2' named entity 'systematic review' named entity 'supportive measures' named entity 'host cells' named entity 'People with diabetes' named entity 'DKA' named entity 'experimental models' named entity 'angiotensin' named entity 'drug interactions' named entity 'ACE2' named entity 'infection control' named entity 'diabetes' named entity 'glycaemic control' named entity 'ACE2' named entity 'diabetes' named entity 'viral pneumonia' named entity 'anti-inflammatory' named entity 'IL-6' named entity 'human coronaviruses' named entity 'glycaemic' named entity 'ACE2' named entity 'COVID-19' named entity 'remdesivir' named entity 'ACE2' named entity 'serum ferritin' named entity 'SARS-CoV-2' named entity 'diabetes' named entity 'angiotensin' named entity 'angiotensin' named entity 'China' named entity 'WHO' named entity 'type 1 diabetes' named entity 'ACE2' named entity 'anti-inflammatory' named entity 'metformin' named entity 'insulin' named entity 'perineal' named entity 'prophylactic' named entity 'ACEI' named entity 'metformin' named entity 'glucose' named entity 'people with diabetes' named entity 'COVID'

Attributes

Values

Creator

Matthews, David
De Silva, Nipun
Dissanayake, Harsha
Gamage, Kavinga
Katulanda, Prasad
Piyumi, &
Ranathunga, Ishara
Ratnasamy, Vithiya
Somasundaram, Noel
Sumanatilleke, Manilka
Wijewickrama, S
Yogendranathan, Nilukshana

is schema:about of

named entity 'group'
named entity 'This'
named entity 'Since'
named entity 'risk'
named entity 'immunomodulatory'
named entity 'rapidly'
named entity 'chemoprophylaxis'
named entity 'COVID-19'
named entity 'injury'
named entity 'diabetes'
named entity 'pandemic'
named entity 'insulin'
named entity 'direct'
named entity 'disease'
named entity 'access'
named entity 'patients'
named entity 'medications'
named entity 'COVID-19'
named entity 'Measures'
named entity 'coronavirus disease 2019'
named entity 'COVID-19'
named entity 'inflammatory response'
named entity 'glycaemic control'
named entity 'healthcare'
named entity 'recognised'
named entity 'vulnerable'
named entity 'severe'
named entity 'COVID-19'
named entity 'people with diabetes'
named entity 'diabetes'
named entity 'prevent disease'
named entity 'inflammatory response'
named entity 'people with diabetes'
named entity 'People with diabetes'
named entity 'people with diabetes'
named entity 'chemoprophylaxis'
named entity 'Older'
named entity 'diabetes'
named entity 'diabetes'
named entity 'ARDS'
named entity 'China'
named entity 'acute illness'
named entity 'angiotensin'
named entity 'pneumonic'
named entity 'Text box'
named entity 'ACE2'
named entity 'systematic review'
named entity 'supportive measures'
named entity 'host cells'
named entity 'People with diabetes'
named entity 'DKA'
named entity 'experimental models'
named entity 'angiotensin'
named entity 'drug interactions'
named entity 'ACE2'
named entity 'infection control'
named entity 'diabetes'
named entity 'glycaemic control'
named entity 'ACE2'
named entity 'diabetes'
named entity 'viral pneumonia'
named entity 'anti-inflammatory'
named entity 'IL-6'
named entity 'human coronaviruses'
named entity 'glycaemic'
named entity 'ACE2'
named entity 'COVID-19'
named entity 'remdesivir'
named entity 'ACE2'
named entity 'serum ferritin'
named entity 'SARS-CoV-2'
named entity 'diabetes'
named entity 'angiotensin'
named entity 'angiotensin'
named entity 'China'
named entity 'WHO'
named entity 'type 1 diabetes'
named entity 'ACE2'
named entity 'anti-inflammatory'
named entity 'metformin'
named entity 'insulin'
named entity 'perineal'
named entity 'prophylactic'
named entity 'ACEI'
named entity 'metformin'
named entity 'glucose'
named entity 'people with diabetes'
named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software